Assessing clinical impact of myocardial perfusion studies: Ischemia or other prognostic indicators?

Todd D. Miller, John Wells Askew, Joerg Herrmann

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

One of the major strengths of nuclear myocardial perfusion imaging (MPI) is the robust prognostic databases from observational studies demonstrating significantly different outcomes in patients with low-risk vs high-risk scans. The severity of the MPI defect can be semi-quantitated using the summed stress score (SSS) and summed difference score (SDS). SSS is more strongly associated with mortality, whereas SDS is the better predictor of subsequent coronary angiography and revascularization. The strength of MPI variables as prognostic indicators decreases when adjusted for prognostically important clinical and stress test variables. Nonetheless, most studies of general patient populations have demonstrated that MPI adds incremental prognostic value to clinical and stress test information. In contrast to these positive results from observational studies, the application of MPI ischemia as a treatment guide in several recent trials (DIAD, WOMEN, COURAGE, BARI 2D, STICH) has largely failed to identify patient subsets with improved outcome. This issue will continue to be investigated in the ongoing PROMISE and ISCHEMIA trials.

Original languageEnglish (US)
JournalCurrent Cardiology Reports
Volume16
Issue number4
DOIs
StatePublished - Jan 1 2014

Fingerprint

Myocardial Perfusion Imaging
Ischemia
Perfusion
Exercise Test
Observational Studies
Coronary Angiography
Databases
Mortality
Population

Keywords

  • Coronary artery disease
  • Ischemia
  • MPI (myocardial perfusion imaging)
  • Prognosis
  • SPECT (single photon emission computed tomography)
  • Summed difference score
  • Summed stress score

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Assessing clinical impact of myocardial perfusion studies : Ischemia or other prognostic indicators? / Miller, Todd D.; Askew, John Wells; Herrmann, Joerg.

In: Current Cardiology Reports, Vol. 16, No. 4, 01.01.2014.

Research output: Contribution to journalReview article

@article{8721bd6147f941dea768cb566f56d27c,
title = "Assessing clinical impact of myocardial perfusion studies: Ischemia or other prognostic indicators?",
abstract = "One of the major strengths of nuclear myocardial perfusion imaging (MPI) is the robust prognostic databases from observational studies demonstrating significantly different outcomes in patients with low-risk vs high-risk scans. The severity of the MPI defect can be semi-quantitated using the summed stress score (SSS) and summed difference score (SDS). SSS is more strongly associated with mortality, whereas SDS is the better predictor of subsequent coronary angiography and revascularization. The strength of MPI variables as prognostic indicators decreases when adjusted for prognostically important clinical and stress test variables. Nonetheless, most studies of general patient populations have demonstrated that MPI adds incremental prognostic value to clinical and stress test information. In contrast to these positive results from observational studies, the application of MPI ischemia as a treatment guide in several recent trials (DIAD, WOMEN, COURAGE, BARI 2D, STICH) has largely failed to identify patient subsets with improved outcome. This issue will continue to be investigated in the ongoing PROMISE and ISCHEMIA trials.",
keywords = "Coronary artery disease, Ischemia, MPI (myocardial perfusion imaging), Prognosis, SPECT (single photon emission computed tomography), Summed difference score, Summed stress score",
author = "Miller, {Todd D.} and Askew, {John Wells} and Joerg Herrmann",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s11886-014-0465-8",
language = "English (US)",
volume = "16",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "4",

}

TY - JOUR

T1 - Assessing clinical impact of myocardial perfusion studies

T2 - Ischemia or other prognostic indicators?

AU - Miller, Todd D.

AU - Askew, John Wells

AU - Herrmann, Joerg

PY - 2014/1/1

Y1 - 2014/1/1

N2 - One of the major strengths of nuclear myocardial perfusion imaging (MPI) is the robust prognostic databases from observational studies demonstrating significantly different outcomes in patients with low-risk vs high-risk scans. The severity of the MPI defect can be semi-quantitated using the summed stress score (SSS) and summed difference score (SDS). SSS is more strongly associated with mortality, whereas SDS is the better predictor of subsequent coronary angiography and revascularization. The strength of MPI variables as prognostic indicators decreases when adjusted for prognostically important clinical and stress test variables. Nonetheless, most studies of general patient populations have demonstrated that MPI adds incremental prognostic value to clinical and stress test information. In contrast to these positive results from observational studies, the application of MPI ischemia as a treatment guide in several recent trials (DIAD, WOMEN, COURAGE, BARI 2D, STICH) has largely failed to identify patient subsets with improved outcome. This issue will continue to be investigated in the ongoing PROMISE and ISCHEMIA trials.

AB - One of the major strengths of nuclear myocardial perfusion imaging (MPI) is the robust prognostic databases from observational studies demonstrating significantly different outcomes in patients with low-risk vs high-risk scans. The severity of the MPI defect can be semi-quantitated using the summed stress score (SSS) and summed difference score (SDS). SSS is more strongly associated with mortality, whereas SDS is the better predictor of subsequent coronary angiography and revascularization. The strength of MPI variables as prognostic indicators decreases when adjusted for prognostically important clinical and stress test variables. Nonetheless, most studies of general patient populations have demonstrated that MPI adds incremental prognostic value to clinical and stress test information. In contrast to these positive results from observational studies, the application of MPI ischemia as a treatment guide in several recent trials (DIAD, WOMEN, COURAGE, BARI 2D, STICH) has largely failed to identify patient subsets with improved outcome. This issue will continue to be investigated in the ongoing PROMISE and ISCHEMIA trials.

KW - Coronary artery disease

KW - Ischemia

KW - MPI (myocardial perfusion imaging)

KW - Prognosis

KW - SPECT (single photon emission computed tomography)

KW - Summed difference score

KW - Summed stress score

UR - http://www.scopus.com/inward/record.url?scp=84894490501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894490501&partnerID=8YFLogxK

U2 - 10.1007/s11886-014-0465-8

DO - 10.1007/s11886-014-0465-8

M3 - Review article

C2 - 24585107

AN - SCOPUS:84894490501

VL - 16

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 4

ER -